Phaeosynt
Phaeosynt is the world's first company to produce antibodies in diatoms and thus offers a vegan and sustainable alternative for diagnostics.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | €1.7m | Seed | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads